OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(2)
2023
(1)
2022
(1)
2019
(1)
2018
(1)
2016
(1)
2015
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).
Not available
S-EPMC3706107
|
biostudies-literature
Cite
The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
Not available
S-EPMC4808327
|
biostudies-literature
Cite
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Not available
S-EPMC6246813
|
biostudies-literature
Cite
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
Not available
S-EPMC6348044
|
biostudies-literature
Cite
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Not available
S-EPMC11181148
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal.
Not available
S-EPMC11328142
|
biostudies-literature
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets